DRAP Guidelines on National Pharmacovigilance System: Indicators
The final article of the cycle provides additional details regarding specific indicators used in the context of a pharmacovigilance system.
The final article of the cycle provides additional details regarding specific indicators used in the context of a pharmacovigilance system.
The new article elaborates further on the existing types of surveillance, highlighting the key points associated thereto.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now